Modafinil for the Treatment of Cocaine Dependence - 1
Phase 2
Completed
- Conditions
- Cocaine-Related Disorders
- Registration Number
- NCT00100100
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.
- Detailed Description
This is a double-blind, placebo-controlled, parallel group design study to evaluate the efficacy and safety of modafinil in reducing cocaine use in subjects with cocaine dependence.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
- Participant must have DSM-IV diagnosis of cocaine dependence as determined by SCID.
- Must be seeking treatment for cocaine dependence.
- Must be able to understand and provide written informed consent.
Exclusion Criteria
- Please contact the study site for more information.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cocaine abstinence
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (6)
Boston University Medical Center
🇺🇸Boston, Massachusetts, United States
New York VA Medical Center
🇺🇸New York, New York, United States
Cincinnati Addiction Research Center
🇺🇸Cincinnati, Ohio, United States
Western Psychiatric Institute & Clinic
🇺🇸Pittsburgh, Pennsylvania, United States
RHD Professional Plaza 4
🇺🇸Dallas, Texas, United States
UTHSCSA
🇺🇸San Antonio, Texas, United States
Boston University Medical Center🇺🇸Boston, Massachusetts, United States